I agree that there will be a takeover premium over and above any valuation method(s) adopted. I believe that there will need to be a reasonable premium to get acceptance of the major shareholders (ie KAH/Polo). The premium will also need to reflect upside on any future drilling - as they are unlikely to have anywhere near completed drilling on the entire resource before any deal is on the table.
Whether the full takeover premium is ever reflected in EXT's share price is debatable - probably not as I believe that there could be a lengthy trading halt as any deal nears finalisation.
With all the drilling happening at the moment I certainly wouldn't expect any analyst to be basing valuations on anything other than known resources - especially since much more will become known within a few months.
I have yet to see anything posted in relation to LE's valuation to have cause for me to consider it way off the mark.
Time will tell.
- Forums
- ASX - By Stock
- EXT
- can you please not moderate my post
EXT
excite technology services ltd
Add to My Watchlist
11.1%
!
1.0¢

can you please not moderate my post, page-23
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.0¢ |
Change
0.001(11.1%) |
Mkt cap ! $20.72M |
Open | High | Low | Value | Volume |
0.9¢ | 1.0¢ | 0.8¢ | $31.15K | 3.390M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1600000 | 0.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.0¢ | 1109800 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1600000 | 0.009 |
6 | 1884688 | 0.008 |
6 | 5198700 | 0.007 |
4 | 2850000 | 0.006 |
2 | 1280000 | 0.005 |
Price($) | Vol. | No. |
---|---|---|
0.010 | 627812 | 2 |
0.011 | 4227645 | 5 |
0.012 | 1982124 | 5 |
0.013 | 53000 | 1 |
0.014 | 1000000 | 1 |
Last trade - 15.23pm 27/06/2025 (20 minute delay) ? |
Featured News
EXT (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online